SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
22/26/22	₩2,670.00	-0.74%	12,43,471
21/26/21	₩2,690.00	-0.37%	17,76,148
18/26/18	₩2,700.00	+1.69%	25,08,873
17/26/17	₩2,655.00	+5.57%	1,20,90,757
16/26/16	₩2,515.00	-0.79%	6,84,892

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 22/09/2026			5-day change	1st Jan Change
2,670.00 ^KRW	-0.74%		+4.30%	+56.05%

01/09	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
19/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI

Market Cap	16TCr 12Cr 10Cr 9.72Cr 8.87Cr 17Cr 1.13TCr 17Cr 116.63Cr 45Cr 577.58Cr 44Cr 43Cr 1.86TCr	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	17TCr 12Cr 11Cr 10Cr 9.26Cr 17Cr 1.18TCr 17Cr 121.84Cr 47Cr 603.41Cr 46Cr 45Cr 1.95TCr	EV / Sales 2025	3.42x	EV / Sales 2026	10.4x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

01/09	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
19/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
13/08	SV Investment Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
02/07	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
18/06	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
29/05	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
28/05	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
21/05	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
14/05	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
14/04	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
25/02	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
13/02	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
14/11	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

1 day	-0.74%
1 week	+4.30%
Current month	+15.09%
1 month	+32.18%
3 months	+21.36%
6 months	-21.59%
Current year	+56.05%

SV Investment Corporation Share Price

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation: SV Investment Corporation

Chart: SV Investment Corporation

Latest news: SV Investment Corporation

Quotes and Performance

Price Extremes

Managers and Directors: SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	2,440	2,910
1 month	2,200	2,910
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Won-Ho Hong CEO	Chief Executive Officer	61	30/09/2019
Seong-Ho Park CEO	Chief Executive Officer	57	-
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	30/06/2023

Director	Title	Age	Since
Seong-Ho Park BRD	Director/Board Member	57	-
Won-Ho Hong BRD	Director/Board Member	61	30/09/2019
Ji-Hwa Ryu BRD	Director/Board Member	56	30/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	-0.74%	+4.30%	+38.34%	+41.12%	12Cr
BB BIOTECH AG	+0.77%	+0.77%	+41.46%	+22.97%	347.88Cr
HERCULES CAPITAL, INC.	-0.26%	-1.90%	-9.59%	+5.33%	320.63Cr
HBM HEALTHCARE INVESTMENTS AG	-1.27%	-2.31%	+33.45%	+32.84%	190.11Cr
MOLTEN VENTURES PLC	-0.74%	+5.39%	+82.99%	+196.35%	143.58Cr
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	72Cr
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+2.98%	+9.08%	+118.16%	+249.85%	65Cr
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.97%	-8.81%	40Cr
OCTOPUS TITAN VCT PLC	-5.41%	0.00%	-28.57%	-73.08%	41Cr
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	37Cr
Average	-0.60%	+1.72%	+27.00%	+44.65%	126.87Cr
Weighted average by Cap.	-0.31%	+0.13%	+28.59%	+44.55%

	2025	2026
Net sales	2TCr 1.47Cr 1.29Cr 1.21Cr 1.1Cr 2.07Cr 140.76Cr 2.07Cr 15Cr 5.6Cr 72Cr 5.53Cr 5.41Cr 231.74Cr	2.05TCr 1.51Cr 1.32Cr 1.24Cr 1.13Cr 2.13Cr 144.52Cr 2.13Cr 15Cr 5.75Cr 74Cr 5.68Cr 5.55Cr 237.92Cr
Net income	-523.22Cr -38.55L -33.69L -31.66L -28.9L -54.23L -37Cr -54.24L -3.8Cr -1.47Cr -19Cr -1.45Cr -1.42Cr -61Cr	-100.12Cr -7L -6L -6L -6L -10.38L -7.05Cr -10.38L -72.72L -28.06L -3.6Cr -27.7L -27.1L -12Cr
Net Debt	-104.08Cr -8L -7L -6L -6L -10.79L -7.33Cr -10.79L -75.6L -29.17L -3.74Cr -28.8L -28.17L -12Cr	717.89Cr 52.9L 46.23L 43.45L 39.65L 74.41L 51Cr 74.42L 5.21Cr 2.01Cr 26Cr 1.99Cr 1.94Cr 83Cr